The Latest Breaking News on Pharma

The health care riders in the year-end spending package that emerged on Monday reflect which health care interests have clout, and which issues lawmakers want to punt into next year.

The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.

China's abrupt end to its zero-COVID policy has raised concerns of widespread infections among a vulnerable, undervaccinated population with little natural immunity that would overload the health system and result in up to 2 million deaths, or more, various research groups are reporting.

A review into a major regional hospital has found no evidence to support the improper sedation of patients despite disciplinary action taken against staff. Patient advocates are calling for the release of the full report that they believe will be 'damning'.

Codeine use has dropped by 37 per cent since over the counter sales were banned, according to new findings from wastewater sampling taken across the nation.

A new report criticizes the Food and Drug Administration’s efforts to oversee the tobacco industry, including traditional cigarettes and vaping products

Medtronic, battered by a high number of serious medical device recalls in recent years, says it is toughening its internal assessments for acquiring new products.

The Department for Health and Social Care has issued legal proceedings against PPE Medpro, which has been at the centre of a row after Tory peer Baroness Mone took a leave of absence from the Lords

THE UK Government has initiated legal action against PPE Medpro, the firm linked to Tory peer Michelle Mone at the centre of a row over Covid…

European Commission vice-president says veterinary medicines may continue to be bought from the rest of the UK until December 2025.

Amid rising global medical needs, the pharmaceutical industry is expected to witness robust growth in the coming years. Moreover, healthcare is considered relatively resilient amid market downturns. So, given the economic uncertainties, investors could consider buying quality pharmaceutical stocks such as Pfizer (PFE), Novartis (NVS), and Bristol-Myers Squibb (BMY) this…